(Q46962037)

26 December 2017

title

Predictors of Lamotrigine-associated rash (English)

1 reference

26 December 2017

author name string

Lawrence J Hirsch

1

1 reference

26 December 2017

David B Weintraub

2

1 reference

26 December 2017

Richard Buchsbaum

3

1 reference

26 December 2017

Hilary T Spencer

4

1 reference

26 December 2017

Tara Straka

5

1 reference

26 December 2017

Melissa Hager

6

1 reference

26 December 2017

Stanley R Resor

7

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

published in

Epilepsia

1 reference

26 December 2017

volume

47

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

318-322

1 reference

26 December 2017

Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Use of anticonvulsants for treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Safety review of adult clinical trial experience with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Concomitant use of divalproex sodium and lamotrigine in developmentally disabled patients with epilepsy: a retrospective evaluation of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Effect of antiepileptic drug comedication on lamotrigine clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Tolerability and pharmacokinetics of oral loading with lamotrigine in epilepsy monitoring units

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

Double-Blind, Placebo-Controlled, Lamotrigine in Treatment-Resistant Generalised Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00423.X

10.1111/J.1528-1167.2006.00423.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16499755

1 reference

26 December 2017